{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:31:11Z","timestamp":1787506271335,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.lungcan.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:31:13Z","timestamp":1381278673000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma"],"prefix":"10.1016","volume":"82","author":[{"given":"Jenette","family":"Creaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur W.","family":"Musk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2013.09.016_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0015","first-page":"1850","article-title":"Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma","volume":"45","author":"Roboz","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.94.5.1037","article-title":"Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma","volume":"94","author":"Pettersson","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jjco\/27.5.293","article-title":"Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma","volume":"27","author":"Atagi","year":"1997","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-007-0375-x","article-title":"Cytological diagnosis of malignant mesothelioma \u2013 improvement by additional analysis of hyaluronic acid in pleural effusions","volume":"450","author":"Welker","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.clinbiochem.2009.03.007","article-title":"Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma","volume":"42","author":"Grigoriu","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0040","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1073\/pnas.1117560109","article-title":"Inhibition of stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis","volume":"109","author":"Hirose","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bj2000415","article-title":"Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit","volume":"200","author":"Fraser","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-1681.1984.tb00235.x","article-title":"Elimination of hyaluronic acid from the blood stream in the human","volume":"11","author":"Fraser","year":"1984","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0055","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thx.2006.068114","article-title":"Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma","volume":"62","author":"Creaney","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0065","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0070","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1097-0142(20010901)92:5<1224::AID-CNCR1441>3.0.CO;2-U","article-title":"Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma","volume":"92","author":"Thylen","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0075","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2000::AID-CNCR17>3.0.CO;2-N","article-title":"Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma","volume":"86","author":"Thylen","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.24013","article-title":"Noninvasive assessment of liver fibrosis","volume":"53","author":"Mart\u00ednez","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"Light","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1711430303","article-title":"Diagnosis of pleural malignant mesothelioma in life \u2013 a practical approach","volume":"143","author":"Whitaker","year":"1984","journal-title":"J Pathol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0095","series-title":"Malignant mesothelioma","first-page":"167","article-title":"Cytological appearances of malignant mesothelioma","author":"Whitaker","year":"1992"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","article-title":"A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit","volume":"45","author":"Segal","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0105","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1055-9965.EPI-10-0346","article-title":"Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma","volume":"19","author":"Creaney","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0115","series-title":"Evaluation, classification, and stratification","author":"National Kidney Foundation","year":"2009"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.lungcan.2011.01.011","article-title":"Mesothelin and kidney function \u2013 analysis of relationship and implications for mesothelioma screening","volume":"73","author":"Boudville","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200811-1729OC","article-title":"Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions","volume":"180","author":"Davies","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","article-title":"Soluble mesothelin-related protein in the diagnosis of malignant pleural mesothelioma","volume":"173","author":"Scherpereel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0135","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1515\/CCLM.2011.242","article-title":"Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma","volume":"49","author":"Yamada","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0140","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1440-1746.2010.06612.x","article-title":"Biomarkers of liver fibrosis","volume":"26","author":"Adams","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0145","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1373\/clinchem.2008.121913","article-title":"Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum","volume":"55","author":"Hollevoet","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0150","first-page":"167","article-title":"Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions","volume":"75","author":"Zaga","year":"2011","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0155","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ajpath.2011.06.005","article-title":"Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome","volume":"179","author":"Josefsson","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0160","doi-asserted-by":"crossref","first-page":"19821","DOI":"10.1074\/jbc.M110.104273","article-title":"Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor","volume":"285","author":"Ghatak","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5009\/gnl.2011.5.4.397","article-title":"The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer","volume":"5","author":"Jang","year":"2011","journal-title":"Gut Liver"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/03008200802143356","article-title":"Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer","volume":"49","author":"Misra","year":"2008","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3199","article-title":"CD44 enhances invasion of basal-like breast cancer cells by up-regulating serine protease and collagen-degrading enzymatic expression and activity","volume":"14","author":"Montgomery","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","article-title":"Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan","volume":"18","author":"Tammi","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0185","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","article-title":"Hyaluronan\u2013CD44 interactions in cancer: paradoxes and possibilities","volume":"15","author":"Toole","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00496570","article-title":"Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining","volume":"397","author":"Kwee","year":"1982","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/dc.20201","article-title":"Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization","volume":"32","author":"Afify","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00121913","article-title":"Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion","volume":"13","author":"Jones","year":"1995","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0205","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s13277-012-0369-4","article-title":"Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells","volume":"33","author":"Tamada","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","article-title":"Hyaluronan fragments: an information-rich system","volume":"85","author":"Stern","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.resinv.2013.02.002","article-title":"Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma","volume":"51","author":"Fujimoto","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.lungcan.2013.09.016_bib0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000081392","article-title":"Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions","volume":"25","author":"Trape","year":"2004","journal-title":"Tumour Biol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213004418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213004418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T05:25:59Z","timestamp":1539321959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213004418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0169500213004418"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.09.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}